Vanderbilt Institute of Chemical Biology
Apr. 20, 2016—New structural details of the binding of the bacterium Streptococcus sanguinis to platelets may offer new therapeutics for life-threatening cardiovascular infections.
Apr. 7, 2016—Philip Low, Ph.D., director of the Purdue Center for Drug Discovery, will deliver the next Flexner Discovery Lecture on April 14.
Jan. 28, 2016—“Stay with science,” Nobel laureate Peter Agre, M.D., advised dozens of medical and graduate students who attended his lecture at Vanderbilt University Medical Center last week. “It will take you to fascinating places.”
Jan. 14, 2016—Peter Agre, M.D., a Nobel laureate who advocates the use of medical science to advance international diplomacy, will deliver the next Flexner Discovery Lecture at 4 p.m. Thursday, Jan. 21, in room 208 Light Hall.
Oct. 2, 2015—New findings add to the understanding of how the enzyme COX-2 works, which is critical to the development of COX-2-targeted anti-inflammatory drugs.
Jun. 17, 2015—A new imaging probe developed by Vanderbilt investigators enhances tumor visibility and has broad applications in diagnosing and monitoring patients with cancer.
Jan. 2, 2015—Jennifer Doudna, Ph.D., recipient of a 2015 Breakthrough Prize in Life Sciences, will deliver the next Flexner Discovery Lecture on Thursday, Jan. 8.
Apr. 16, 2014—A new compound that activates potassium channels could be used to treat disorders of glucose homeostasis.
Apr. 15, 2014—Vanderbilt researchers have identified a new signaling system that anthrax bacteria uses to infect its host.
Feb. 6, 2014—The antioxidant vitamin E prevented the buildup of toxic products in a model of a rare genetic disorder, suggesting new strategies for therapeutic development.
Jan. 24, 2014—Nine Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration Jan. 22 at the Student Life Center.
Sep. 18, 2013—Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.